Gasco Saudi Arabia and Hexagon Ragasco sign a five-year distribution agreement for new, custom-sized LPG cylinders.
18 October 2023: National Gas and Industrial Company (Gasco), the largest Liquefied Petroleum Gas (LPG) distributor in the Kingdom of Saudi Arabia, and Hexagon Composites' subsidiary Hexagon Ragasco have signed a long-term distribution agreement. The five-year contract (2023-2028) covers the provision and distribution of custom-made LPG cylinders on the Saudi Arabian domestic market and is valued at approximately 20 million euros.
Gasco has played a significant role in the development of the composite cylinder market in Saudi Arabia, which is the largest market for domestic LPG utilization in the Middle East. Since 2015, Hexagon Ragasco has been a supplier to Gasco.
A Collaborative Strategy for Enhancing Operational Effectiveness
The new custom-sized composite cylinder by Hexagon Ragasco is specifically designed to increase Gasco’s filling and logistical operational efficiency. The broader and shorter cylinder fits seamlessly with Gasco’s filling systems and logistic equipment, making filling, storage, and transport of the cylinders more streamlined and efficient.
“We are pleased to have this agreement in place with our long-time partner, Hexagon Ragasco. Hexagon Ragasco’s collaborative approach continually adds value to our business. The new cylinder is designed specifically for our existing pallets and bottling systems, allowing us to fill and deliver modern LPG composite cylinders more cost-effectively to customers that reap the benefits of lightweight, durable composite cylinders and a lower CO2 footprint" says Eng. Abdulrahman Bin Sulaiman, CEO of Gasco.
The new cylinder will be manufactured at Hexagon Ragasco’s world-class, high-volume, fully automated production facility in Raufoss, Norway.
"This is our second long-term distribution agreement with Gasco—an alliance that has strengthened our position in the Middle East region over the last decade. As a preferred supplier, we are able to engage with Gasco’s team and help them address some of the operational challenges that face business growth in a key region for both the LPG industry and Hexagon Ragasco," says Skjalg Stavheim, President of Hexagon Ragasco. "Today’s announcement is an example of the role customer intimacy plays in driving innovation."
The first new composite LPG cylinders will be shipped and introduced to the Saudi market in 2024.
For more information:
Karen Romer, SVP Communications, Hexagon Composites ASA
Telephone: +47 950 74 950 | email@example.com
Ingrid Aarsnes, VP Investor Relations and ESG, Hexagon Composites ASA
Telephone: +47 950 38 364 | firstname.lastname@example.org
About National Gas and Industrial Company (Gasco)
Gasco was incorporated in 1963 (1383H) via the merger of National Gas Company in Dammam and its two branches in Riyadh and Jeddah, together with Saudi manufacturing and Gas Company in Riyadh and its branches in Dammam.
Gasco's main activities are transportation, filling, distributing, and marketing of Liquefied Petroleum Gas (LPG), which consists of propane (C3H8), butane (C4H10), or a mixture of both. Gasco has generated revenues of more than SAR 2 billion in 2022.
About Hexagon Ragasco AS
At Hexagon Ragasco, we are committed to quality, safety, and innovation. We are the leading manufacturer of composite LPG cylinders, with an industry-leading safety record of 20+ years and more than 20 million cylinders sold worldwide. Our products bring unique benefits to both LPG marketers and their customers.
LPG has a significant role to play as a transitional energy source with the potential to improve air quality and health for billions of people who rely on highly polluting and toxic fuels as their primary energy source. We believe in cleaner air and safer LPG for everyone, everywhere.
Learn more at www.hexagonragasco.com and follow @Hexagon_Ragasco on Twitter and LinkedIn.
About Hexagon Composites
Hexagon delivers safe and innovative solutions for a cleaner energy future. Our solutions enable storage, transportation, and conversion to clean energy in a wide range of mobility, industrial and consumer applications.
Learn more at hexagongroup.com and follow @HexagonASA on Twitter and LinkedIn
This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This stock exchange release was published by Ingrid Aarsnes, VP IR & ESG, Hexagon Composites ASA on 18 October 2023 at 18:45 CEST.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Managers’ transactions9.12.2023 18:12:40 CET | Press release
December 9, 2023 Announcement no. 21 Managers’ transactions COPENHAGEN, DENMARK and BOSTON, MA, December 9, 2023, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or the Company) (CPH:BIOPOR), has received notice pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transaction related to shares in BioPorto made by persons discharging managerial responsibilities in BioPorto and/or persons closely related with them. 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Singer Asefzadeh Family Holding Trust 2. Reason for the notification a) Position/status Closely associated person to Michael S. Singer, member of the Board of Directors of BioPorto A/S b) Initial notification/amendment Initial notification 3. Details of the issuer a) Name BioPorto A/S b) LEI 5299004SWFL5JAN4W830 4. Details of the transaction(s) a) Description of the financial instrument type of instrument and Identification code Shares, ISIN code DK0011048619 b) Nature o
New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)9.12.2023 18:00:00 CET | Press release
Media Release COPENHAGEN, Denmark; December 9, 2023 Data from the pivotal phase 1/2 EPCORE™ NHL-1 study showed 82 percent overall response rate (ORR), 63 percent complete response (CR) and 67 percent minimal residual disease (MRD) negativity in patients with relapsed/refractory (R/R) follicular lymphoma (FL) treated with subcutaneous epcoritamab Results presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition include data from an optimized step-up dosing schedule for FL patients showing meaningful reduction in risk and severity of cytokine release syndrome (CRS) Follicular lymphoma is the second most common form of non-Hodgkin’s lymphoma, is considered incurable and can be difficult to treat in the R/R setting Genmab A/S (Nasdaq: GMAB) and AbbVie (NYSE: ABBV) todayannounced new data from the ongoing phase 1/2 EPCORE™ NHL-1 clinical trial investigating epcoritamab (DuoBody® CD3xCD20), a T-cell engaging bispecific antibody administered subcutaneously, demo
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG51019.12.2023 18:00:00 CET | Press release
Additional safety and efficacy data further support potential of innovative, decentralized approach to CAR-T manufacturing and transformational impact on patients with severe hematologic cancersTwo poster presentations include recent data updates and additional data not included in the ASH abstracts Galapagos to host a Key Opinion Leader (KOL) event with live webcast on Sunday, 10 December 2023 at 11:00 am PT/20:00 CET Mechelen, Belgium; 9 December 2023, 18:00 CET; Galapagos NV (Euronext & NASDAQ: GLPG) topresent additional encouraging clinical data from the ongoing Phase 1/2 CD19 CAR-T studies, EUPLAGIA-1 with GLPG5201 and ATALANTA-1 with GLPG5101, in patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or without Richter transformation, and non-Hodgkin lymphoma (rrNHL), during two poster sessions at the 65th American Society of Hematology (ASH) Annual Meeting taking place in San Diego, from 9-12 December. “We are very pleased to share promising new data from o
New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia A9.12.2023 17:30:00 CET | Press release
Phase III HAVEN 7 primary data presented at ASH 2023 provide additional confidence in the favourable efficacy and safety profile of subcutaneous Hemlibra given soon after birth 1At nearly two years median follow-up in the descriptive, single-arm study, no babies experienced spontaneous bleeds requiring treatment, and all treated bleeds were as a result of trauma 1Safety results were consistent with previous studies of Hemlibra, with no new safety signals observed 1The HAVEN 7 study was developed in collaboration with the haemophilia A community, to generate additional evidence for the prophylactic treatment of infants with haemophilia A Basel, 09 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the primary analysis of the Phase III HAVEN 7 study reinforced the efficacy and safety of Hemlibra® (emicizumab) in previously untreated or minimally treated infants with severe haemophilia A without factor VIII inhibitors. Results showed that Hemlibra achieved meaningful
Bulletin from Annual General Meeting in SkiStar AB9.12.2023 16:00:00 CET | Press release
At SkiStar AB (publ)’s annual general meeting, held in Sälen on 9 December 2023, the following decisions were made. A dividend of SEK 2.60 per share was adopted. Record day 12 December 2023.Lena Apler, Fredrik Paulsson, Gunilla Rudebjer, Anders Sundström, Anders Svensson and Vegard Søraunet were re-elected to the board and Carina Åkerström was elected as new board member.Anders Sundström was re-elected chairman of the board.Board fees, including committee fees, were raised to a total of SEK 2,890,000 (2022: SEK 2,810,000). The fees shall be distributed as follows: SEK 670,000 (650,000) to the chairman of the board and SEK 310,000 (300,000) each to the other non-executive directors. Audit committee members will receive total fees of SEK 240,000 (unchanged), distributed as follows: SEK 120,000 to the committee chairman and SEK 60,000 to each of the other two members. Remuneration committee members will receive total fees of SEK 120,000 (unchanged), distributed as follows: SEK 60,000 to t